Analgesics in Kazakhstan

Analgesics is projected to continue to post fast retail volume growth over 2023. The potential for even higher growth is restricted by many households retaining stocks of analgesics purchased during the Coronavirus (COVID-19) pandemic. One clear trend is a shift to ibuprofen, combination products and acetaminophen, which are gaining ground on aspirin. Indeed paediatric ibuprofen and adult ibuprofen are expected to register the fastest retail volume growth for a second consecutive year in 2023.

The Analgesics in Kazakhstan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Analgesics market
• Pinpoint growth sectors and identify factors driving change
• Understand the competitive environment, the market’s major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

The analyst has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, The analyst has a unique capability to develop reliable information resources to help drive informed strategic planning.